Icon of Kadmon ASSIST logo

Enroll your patients with cGVHD in Kadmon ASSIST so our specialists can determine which programs are available to patients.

For full Terms and Conditions, and to enroll patients in Kadmon ASSIST, please visit KadmonASSIST.com or call 1-844-KADMON1 (523-6661), Monday through Friday, 8 AM-8 PM ET.

Kadmon ASSIST offers coverage verification, financial assistance and patient support services for eligible patients

circular insurance card icon

Navigating coverage and providing insurance assistance

circular pill bottle icon

Providing a free 30-day supply of REZUROCK to eligible patients who experience delays or gaps in their insurance coverage

circular dollar currency icon

Co-pay savings programa for commercially or privately insured patients

aPatient Terms and Conditions: The Kadmon ASSIST Commercial Co-pay Savings Program provides co-pay/coinsurance support for out-of-pocket costs on REZUROCK® (belumosudil) tablets prescriptions. A yearly maximum benefit applies. Limit one 30-day supply per 30 days. This program is not health insurance. This program is for commercially or privately insured patients only; uninsured or cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state- or federally funded programs, including, but not limited to, Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, TriCare, private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. The co-pay program may not be combined with any other rebate, coupon or offer. Sanofi reserves the right to rescind, revoke or amend this offer at any time without further notice. Any savings provided by the program may vary depending on patients' out-of-pocket costs. This program is intended to help patients afford REZUROCK. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms. Card is valid through December 31 of the year of activation. On January 1 of the following year, the card automatically resets and is subject to annual limits if the prescription benefit remains the same. A representative of Sanofi may contact the patient for follow up on any adverse event that may be reported. Upon registration, patients receive all program details.

cGVHD, chronic graft-versus-host disease; MOA, mechanism of action.